BACKGROUND: Surgery is an important therapeutic option in patients with medically refractory epilepsy. The combination of an extratemporal epileptic focus and nonlesional magnetic resonance imaging (MRI) was often believed to portend a poor outcome. OBJECTIVE: To investigate the outcome and analyze potential prognostic predictors in patients without lesions on MRI who underwent extratemporal resections. METHODS: Clinical, presurgical evaluation, invasive monitoring, and postoperative data of patients with high-resolution MRI that was initially reported as nonlesional were reviewed. Patients were reclassified as MRI-positive if an MRI abnormality related to the epilepsy was revealed at the multidisciplinary presurgical patient management conference, or as MRI-negative if imaging remained normal or revealed incidental findings. RESULTS: Sixty patients were identified; 72% were MRI-negative. In the original cohort, the median seizure-free duration was 1.32 years (95% confidence interval [CI], 0.16-2.0); probability of seizure freedom at 2 years was 36% (95% CI, 30%-43%). In the MRI-negative group, the median seizure-free duration was 1.52 years (95% CI, 0.12-5.17); probability of seizure freedom at 2 years was 42% (95% CI, 33%-50%). Complete resection of ictal onset areas and absence of acute postoperative seizures were significantly associated with longer seizure freedom (risk ratio 4.9, P = .004; 95% CI, 1.6-16.7 and 22.1, P < .001; 95% CI, 5.9-94.7, respectively). CONCLUSION: Among patients with medically refractory MRI nonlesional extratemporal epilepsy, detailed evaluation and subsequent resection leads to seizure freedom in 42% of patients at 2 years.
BACKGROUND: Surgery is an important therapeutic option in patients with medically refractory epilepsy. The combination of an extratemporal epileptic focus and nonlesional magnetic resonance imaging (MRI) was often believed to portend a poor outcome. OBJECTIVE: To investigate the outcome and analyze potential prognostic predictors in patients without lesions on MRI who underwent extratemporal resections. METHODS: Clinical, presurgical evaluation, invasive monitoring, and postoperative data of patients with high-resolution MRI that was initially reported as nonlesional were reviewed. Patients were reclassified as MRI-positive if an MRI abnormality related to the epilepsy was revealed at the multidisciplinary presurgical patient management conference, or as MRI-negative if imaging remained normal or revealed incidental findings. RESULTS: Sixty patients were identified; 72% were MRI-negative. In the original cohort, the median seizure-free duration was 1.32 years (95% confidence interval [CI], 0.16-2.0); probability of seizure freedom at 2 years was 36% (95% CI, 30%-43%). In the MRI-negative group, the median seizure-free duration was 1.52 years (95% CI, 0.12-5.17); probability of seizure freedom at 2 years was 42% (95% CI, 33%-50%). Complete resection of ictal onset areas and absence of acute postoperative seizures were significantly associated with longer seizure freedom (risk ratio 4.9, P = .004; 95% CI, 1.6-16.7 and 22.1, P < .001; 95% CI, 5.9-94.7, respectively). CONCLUSION: Among patients with medically refractory MRI nonlesional extratemporal epilepsy, detailed evaluation and subsequent resection leads to seizure freedom in 42% of patients at 2 years.
Authors: Aleksandar J Ristic; Z Irene Wang; Chong H Wong; Stephen E Jones; Imad M Najm; Felix Schneider; Shuang Wang; Jorge A Gonzalez-Martinez; W Bingaman; Andreas V Alexopoulos Journal: Epilepsia Date: 2013-10-01 Impact factor: 5.864
Authors: Z Irene Wang; Stephen E Jones; Zeenat Jaisani; Imad M Najm; Richard A Prayson; Richard C Burgess; Balu Krishnan; Aleksandar Ristic; Chong H Wong; William Bingaman; Jorge A Gonzalez-Martinez; Andreas V Alexopoulos Journal: Ann Neurol Date: 2015-04-23 Impact factor: 10.422
Authors: Lara Jehi; Daniel Friedman; Chad Carlson; Gregory Cascino; Sandra Dewar; Christian Elger; Jerome Engel; Robert Knowlton; Ruben Kuzniecky; Anne McIntosh; Terence J O'Brien; Dennis Spencer; Michael R Sperling; Gregory Worrell; Bill Bingaman; Jorge Gonzalez-Martinez; Werner Doyle; Jacqueline French Journal: Epilepsia Date: 2015-08-07 Impact factor: 5.864
Authors: Robert A McGovern; Ahsan N V Moosa; Lara Jehi; Robyn Busch; Lisa Ferguson; Ajay Gupta; Jorge Gonzalez-Martinez; Elaine Wyllie; Imad Najm; William E Bingaman Journal: Epilepsia Date: 2019-11-02 Impact factor: 5.864
Authors: Hye-Jin Moon; Dong Wook Kim; Chun-Kee Chung; Jung-Won Shin; Jangsup Moon; Bong Su Kang; Soon-Tae Lee; Keun-Hwa Jung; Kon Chu; Ki-Young Jung; Yong Won Cho; Sang Kun Lee Journal: J Epilepsy Res Date: 2016-12-31
Authors: Jorge Gonzalez-Martinez; Sridevi V Sarma; Adam Li; Chester Huynh; Zachary Fitzgerald; Iahn Cajigas; Damian Brusko; Jonathan Jagid; Angel O Claudio; Andres M Kanner; Jennifer Hopp; Stephanie Chen; Jennifer Haagensen; Emily Johnson; William Anderson; Nathan Crone; Sara Inati; Kareem A Zaghloul; Juan Bulacio Journal: Nat Neurosci Date: 2021-08-05 Impact factor: 24.884